SV-102

N/A

Report date: 2026/05/13 09:17:12

Base Information

Drug NameSV-102
Drug Alias NameSV-102SV102SYNC-T SV-102
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > CpG ODNBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 agonistsAnti-CTLA4Anti-PD-1 +[4] 
TargetsTumor necrosis factor receptor superfamily member 5Cytotoxic T-Lymphocyte-Associated Antigen 4Programmed cell death protein 1 +[4] 
Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMexico
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSyncromune Inc
China Registration ClassN/A

Develop Information

Active CompaniesSyncromune Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms, Castration-Resistant
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A